Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof

US11136296B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11136296-B2
Application numberUS-201816603719-A
CountryUS
Kind codeB2
Filing dateApr 4, 2018
Priority dateApr 10, 2017
Publication dateOct 5, 2021
Grant dateOct 5, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to novel substituted N-arylethyl-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) in which Ar represents phenyl or represents pyridyl, where phenyl may be up to tetrasubstituted and pyridyl up to disubstituted, in each case identically or differently, by fluorine, chlorine, by up to tri-fluorine-substituted (C 1 -C 4 )-alkyl, up to tetra-fluorine-substituted (C 3 -C 4 )-cycloalkyl, up to tri-fluorine-substituted (C 1 -C 2 )-alkoxy, or up to tri-fluorine-substituted (C 1 -C 2 )-alkylsulfanyl, or where two substituents of the phenyl or pyridyl group, if they are attached to adjacent ring atoms, are optionally attached to one another in such a way that they together form a methylenedioxy or ethylenedioxy group, or where phenyl may be up to pentasubstituted by fluorine, Y represents a bond or a group of the formula where # 1 represents the attachment site to the carbon atom, # 2 represents the attachment site to the carboxyl group, X represents a bond, —CH 2 —, —O—, —S(═O) m — or —N(R 11 )—, in which m represents 0, 1 or 2 and  R 11 represents hydrogen or methyl,  R 10A and R 10B independently of one another represent hydrogen, fluorine or methyl, or R 10A and R 10B together with the carbon atom to which they are attached form a cyclopropyl group, k represents 1, 2, 3 or 4, R 1 represents halogen, up to penta-fluorine-substituted (C 1 -C 4 )-alkyl, up to tri-fluorine-substituted methoxy, (trifluoromethyl)sulfanyl, pentafluorosulfanyl, trimethylsilyl, ethynyl, cyclopropyl or cyclobutyl, where cyclopropyl and cyclobutyl may be up to tetrasubstituted by fluorine, R 2 , R 3 and R 4 independently of one another represent hydrogen, halogen or up to tri-fluorine-substituted methyl, R 5 represents halogen, up to penta-fluorine-substituted (C 1 -C 4 )-alkyl, up to tri-fluorine-substituted methoxy, hydroxyl, methylsulfanyl, (trifluoromethyl)sulfanyl, cyano, ethenyl, cyclopropyl or cyclobutyl, where cyclopropyl and cyclobutyl may be up to tetrasubstituted by fluorine, R 6 represents phenyl which may be up to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine, methyl, which is up to trisubstituted by fluorine, and methoxy, which is up to trisubstituted by fluorine, or represents thienyl which may be mono- or disubstituted by methyl or monosubstituted by chlorine or bromine, or represents thiazolyl or pyridyl, R 7A and R 7B independently of one another represent hydrogen or methyl, or R 7A and R 7B together with the carbon atom to which they are attached form a cyclopropyl group, R 8 represents hydrogen, fluorine, methyl, trifluoromethyl, ethyl or hydroxyl, R 9 represents hydrogen or methyl, and/or an N-oxide, salt, solvate, salt of an N-oxide and solvate of an N-oxide and/or salt thereof. 2. The compound of formula (I) as claimed in claim 1 , in which Ar represents phenyl or represents 2-pyridyl, where phenyl may be up to tetrasubstituted by fluorine or up to trisubstituted by identical or different fluorine, chlorine, methyl, trifluoromethyl, difluoromethyl, methoxy, difluoromethoxy, trifluoromethoxy or ethoxy substituents, or where two substituents of the phenyl group, if they are attached to adjacent ring atoms, are optionally attached to one another in such a way that they together form a methylenedioxy group, and where 2-pyridyl may be up to disubstituted by identical or different substituents from the group consisting of chlorine and methoxy, Y is a bond or a group of the formula # 1 —X—(CR 10A R 10B ) k —# 2 where # 1 represents the attachment site to the carbon atom, # 2 represents the attachment site to the carboxyl group, X represents a bond, —CH 2 —, —O—, —S(═O) m — or —N(R 11 )—, in which m represents 0 or 2 and R 11 represents hydrogen or methyl, R 10A and R 10B are independently hydrogen, fluorine or methyl, k represents 1, 2 or 3, R 1 represents chlorine, bromine, iodine, methyl, isopropyl, tert-butyl, difluoromethyl, trifluoromethyl, trifluoromethoxy, (trifluoromethyl)sulfanyl, trimethylsilyl, ethynyl, cyclopropyl or cyclobutyl, R 2 represents hydrogen, R 3 and R 4 independently of one another represent hydrogen, chlorine or methyl, R 5 represents fluorine, chlorine, bromine, iodine, methyl, ethyl, propyl, monofluoromethyl, difluoromethyl, trifluoromethyl, methoxy, trifluoromethoxy, hydroxy, methylsulfanyl or cyclopropyl, and R 6 represents phenyl which may be mono- or disubstituted by identical or different fluorine or chlorine substituents or monosubstituted by methyl, trifluoromethyl, methoxy or trifluoromethoxy, or represents thienyl which may be mono- or disubstituted by methyl or monosubstituted by chlorine or bromine, R 7A represents hydrogen or methyl, R 7B represents hydrogen, R 8 represents hydrogen, fluorine, methyl, ethyl or hydroxy, R 9 represents hydrogen, and/or a salt, solvate and/or solvate of a salt thereof. 3. The compound of formula (I) as claimed in claim 1 , in which Ar represents phenyl, where phenyl may be up to tetrasubstituted by fluorine or up to trisubstituted by identical or different fluorine, chlorine, methyl, trifluoromethyl, difluoromethyl, methoxy, difluoromethoxy or trifluoromethoxy substituents, Y represents a group of the formula # 1 —(CH 2 ) n —# 2 where # 1 represents the attachment site to the carbon atom, # 2 represents the attachment site to the carboxyl group, n represents 1, 2 or 3, R 1 represents bromine or ethynyl, R 2 , R 3 and R 4 each represent hydrogen, R 5 represents chlorine or methyl, and R 6 represents phenyl which may be monosubstituted by fluorine, R 7A and R 7B each represent hydrogen, R 8 represents hydrogen or methyl, R 9 represents hydrogen, and/or a salt, solvate and/or solvate of a salt thereof. 4. The compound of formula (I) as claimed in claim 1 , in which Ar represents phenyl, where phenyl may be up to tetrasubstituted by fluorine or up to trisubstituted by identical or different fluorine, chlorine, methyl, trifluoromethyl, difluoromethoxy or trifluoromethoxy substituents, Y represents a group of the formula # 1 —CH 2 CH 2 —# 2 where # 1 represents the attachment site to the carbon atom, # 2 represents the attachment site to the carboxyl group, R 1 represents bromine or ethynyl, R 2 , R 3 , R 4 each represent hydrogen, R 5 represents methyl or chlorine, R 6 represents phenyl, R 7A , R 7B , R 8 and R 9 are each hydrogen, and/or a salt, solvate and/or solvate of a salt thereof. 5. A process for preparing a compound of formula (I) as defined in claim 1 , comprising: [A] reacting a compound of formula (II) with activation of the carboxylic acid function, with an amine compound of formula (III-A) to obtain a compound of formula (I) or with an amine compound of formula (III-B) in which T represents an ester protecting group, to obtain a compound of formula (I

Assignees

Inventors

Classifications

  • C07D215/50Primary

    attached in position 4 · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • Non-condensed quinolines and containing further heterocyclic rings · CPC title

  • Quinolines; Isoquinolines · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11136296B2 cover?
The present application relates to novel substituted N-arylethyl-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and infla…
Who is the assignee on this patent?
Bayer Ag, Bayer Pharma AG
What technology area does this patent fall under?
Primary CPC classification C07D215/50. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).